ACCOUNTS - Final Accounts


Caseware UK (AP4) 2018.0.196 2018.0.196 2019-07-312019-07-31The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.truetruepromotion of educational course in the field of naturopathy and complementary medicinefalse2018-08-01 04226835 2018-08-01 2019-07-31 04226835 2019-07-31 04226835 2018-07-31 04226835 c:Director1 2018-08-01 2019-07-31 04226835 d:CurrentFinancialInstruments 2019-07-31 04226835 d:CurrentFinancialInstruments 2018-07-31 04226835 d:RetainedEarningsAccumulatedLosses 2019-07-31 04226835 d:RetainedEarningsAccumulatedLosses 2018-07-31 04226835 c:FRS102 2018-08-01 2019-07-31 04226835 c:AuditExempt-NoAccountantsReport 2018-08-01 2019-07-31 04226835 c:AbridgedAccounts 2018-08-01 2019-07-31 04226835 c:PublicLimitedCompanyPLCNotQuotedOnAnyExchange 2018-08-01 2019-07-31 04226835 c:CompanyLimitedByGuarantee 2018-08-01 2019-07-31 iso4217:GBP

Registered number: 04226835









CNM THE COLLEGE OF NATUROPATHIC & COMPLEMENTARY MEDICINE LTD
(A company limited by guarantee)








FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JULY 2019


 
CNM THE COLLEGE OF NATUROPATHIC & COMPLEMENTARY MEDICINE LTD
  
(A company limited by guarantee)
REGISTERED NUMBER:04226835

BALANCE SHEET
AS AT 31 JULY 2019

2019
2018
Note
£
£

  

Current assets
  

Debtors
 3 
166,847
166,847

Current asset investments
 4 
96,000
128,000

Cash at bank and in hand
 5 
194,060
162,120

  
456,907
456,967

Total assets less current liabilities
  
 
 
456,907
 
 
456,967

Net assets
  
456,907
456,967


Capital and reserves
  

Profit and loss account
  
456,907
456,967

Shareholders' funds
  
456,907
456,967


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 16 January 2020.




Gunilla Gerber
Director

The notes on pages 2 to 3 form part of these financial statements.

Page 1


 
CNM THE COLLEGE OF NATUROPATHIC & COMPLEMENTARY MEDICINE LTD
 
(A company limited by guarantee)
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2019

1.


General information

The Company is incorporated in England and Wales and is limited by guarantee. The registered office is located at Unit 1, Bulrushes Farm, Coombe Hill Road, East Grinstead, West Sussex  RH19 4LZ.
The principal activity of the company continues to be that of promotion of educational course in the field of naturopathy and complimentary medicine.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A) of the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Debtors

Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.3

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.4

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares.

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or financed at a rate of interest that is not a market rate or in the case of an out-right short-term loan not at market rate, the financial asset or liability is measured, initially, at the present value of the future cash flow discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost.

Page 2


 
CNM THE COLLEGE OF NATUROPATHIC & COMPLEMENTARY MEDICINE LTD
 
(A company limited by guarantee)
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2019

3.


Debtors

2019
2018
£
£


Other debtors
166,847
166,847

166,847
166,847



4.


Current asset investments

2019
2018
£
£

Unlisted investments
96,000
128,000

96,000
128,000



5.


Cash and cash equivalents

2019
2018
£
£

Cash at bank and in hand
194,060
162,120

194,060
162,120




6.


Company status

The company is a private company limited by guarantee and consequently does not have share capital. Each of the members is liable to contribute an amount not exceeding £1 towards the assets of the company in the event of liquidation.

 
Page 3